Plasma levels of p-tau181 and NfL may be used as a biomarker for psychosis in mild cognitive impairment and Alzheimer disease, with potential implications for disease monitoring and treatment strategies. ja.ma/46A3Oz1
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 